Tryptophan and Nicotinic Acid Metabolism in Bladder and Kidney Tumor Patients
Author Information
Author(s): A. Alifano, S. Papa, F. Tancredi, M. A. Elicio, E. Quagliariello
Primary Institution: Institute of Biological Chemistry, University of Bari, and Institute of Biological Chemistry, University of Naples, Italy
Hypothesis
The excretion of 3-hydroxyanthranilic acid in the urine of patients with tumors of the urinary bladder and kidney is altered compared to normal subjects.
Conclusion
Patients with primary carcinomas of the urinary tract excrete greater amounts of 3-hydroxyanthranilic acid than normal controls.
Supporting Evidence
- Patients with bladder cancer excreted larger amounts of 3-hydroxyanthranilic acid than normal subjects.
- 3-Hydroxyanthranilic acid was consistently found in the urine of patients with primary carcinomas of the renal pelvis.
- Previous studies indicated that 3-hydroxyanthranilic acid can induce cancer in experimental models.
Takeaway
This study found that people with bladder and kidney tumors have more of a certain chemical in their urine than healthy people.
Methodology
Urine samples were collected, acidified, centrifuged, and analyzed for 3-hydroxyanthranilic acid using chromatography and colorimetric methods.
Limitations
The study did not account for potential confounding factors such as diet or other health conditions.
Participant Demographics
Patients included those with primary carcinoma of the bladder and kidney tumors.
Want to read the original?
Access the complete publication on the publisher's website